GenLumina (Drug Discovery) Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $1M

  • Investors
  • 4

GenLumina (Drug Discovery) General Information

Description

Developer of a DNA nanotechnology and light-activated drugs intended to transform cancer treatment and eliminate cancer. The company specializes in using light controlled treatment and nanocluster technology that kills cancer cells without damaging healthy tissue, providing oncology researchers and healthcare providers with a minimally invasive, highly targeted therapeutic approach that reduces side effects and improves treatment precision.

Contact Information

Website
www.genlumina.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Langegracht 70
  • 2312 NV Leiden
  • Netherlands
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Langegracht 70
  • 2312 NV Leiden
  • Netherlands

GenLumina (Drug Discovery) Timeline

20252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GenLumina (Drug Discovery) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 17-Jun-2025 $1M Completed Pre-Clinical Trials
2. Accelerator/Incubator 01-Jan-2024 Completed Pre-Clinical Trials
1. University Spin-Out 13-Aug-2024 Completed Pre-Clinical Trials
To view GenLumina (Drug Discovery)’s complete valuation and funding history, request access »

GenLumina (Drug Discovery) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GenLumina (Drug Discovery) Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
UNIIQ Venture Capital Minority
Leiden University University Minority
Libertatis Ergo Holding (LEH) Venture Capital Minority
unlock_ Accelerator/Incubator
To view GenLumina (Drug Discovery)’s complete investors history, request access »

Ready to get started?

Request a free trial

GenLumina (Drug Discovery) FAQs

  • When was GenLumina (Drug Discovery) founded?

    GenLumina (Drug Discovery) was founded in 2024.

  • Where is GenLumina (Drug Discovery) headquartered?

    GenLumina (Drug Discovery) is headquartered in Leiden, Netherlands.

  • What is the size of GenLumina (Drug Discovery)?

    GenLumina (Drug Discovery) has 7 total employees.

  • What industry is GenLumina (Drug Discovery) in?

    GenLumina (Drug Discovery)’s primary industry is Drug Discovery.

  • Is GenLumina (Drug Discovery) a private or public company?

    GenLumina (Drug Discovery) is a Private company.

  • What is GenLumina (Drug Discovery)’s current revenue?

    The current revenue for GenLumina (Drug Discovery) is .

  • How much funding has GenLumina (Drug Discovery) raised over time?

    GenLumina (Drug Discovery) has raised $1M.

  • Who are GenLumina (Drug Discovery)’s investors?

    UNIIQ, Leiden University, Libertatis Ergo Holding (LEH), and unlock_ have invested in GenLumina (Drug Discovery).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process